# Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants

> **NCT03516188** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universiti Sains Malaysia** · enrollment: 24 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease
- Acid Reflux
- Obesity

## Interventions

- **DRUG:** Alginate-antacid group
- **DRUG:** Non antacid alginate group

## Key facts

- **NCT ID:** NCT03516188
- **Lead sponsor:** Universiti Sains Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03516188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03516188, "Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT03516188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*